Infants of COVID-19-Infected Mothers Doing Well in Short Term
No differences seen in rates of preterm birth, NICU admission, respiratory disease with infection
<10 Percent of U.S. Population Has Antibodies to SARS-CoV-2
Comparing seroprevalence and case counts shows only 9.2 percent of seropositive patients diagnosed
Clinical Severity Lower With Vitamin D Sufficiency in COVID-19
Of patients aged ≥40 who died, 9.7 percent were vitamin D-sufficient versus 20 percent with 25(OH)D <30 ng/mL
HRRP Tied to Decrease in 30-Day Readmission Rates for COPD
But increase seen in 30-day risk-standardized postdischarge mortality rates for COPD patients
One-Fifth of Those With SARS-CoV-2 Infection Asymptomatic
No significant differences seen in mean cycle threshold values for asymptomatic, symptomatic patients
Median Age of COVID-19 Cases Declined in May to August in U.S.
In Southern U.S., increases in positive PCR tests in adults age 20 to 39 preceded those in adults ≥60
U.S. Non-English Speakers Less Likely to Have SARS-CoV-2 Test
Seattle study shows non-English speakers less likely to complete testing but more likely to test positive
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Acute Kidney Injury Ups Risk for Death in COVID-19 Patients
Findings based on large study of hospitalized patients in New York City early in the pandemic
Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021
If it passes final round of human tests, SinoVac will apply to the FDA to sell CoronaVac vaccine
